Clinical Trial for Lung Cancer Therapy to Begin at UIC
CHICAGO, Feb. 21 -- The University of Illinois's Chicago campus issued the following news release:
Patients are being recruited for a clinical trial of a new immunotherapy combination for treating metastatic non-small cell lung cancer at the University of Illinois at Chicago.
Lung cancer affects approximately 415,000 Americans and is the leading cancer killer in both men and women, accounting for about 27 percent of all cancer deaths.
"Lung cance . . .
Patients are being recruited for a clinical trial of a new immunotherapy combination for treating metastatic non-small cell lung cancer at the University of Illinois at Chicago.
Lung cancer affects approximately 415,000 Americans and is the leading cancer killer in both men and women, accounting for about 27 percent of all cancer deaths.
"Lung cance . . .